Lleo A. SVR is the strongest predictor of occurrence and recurrence of hepatocellular carcinoma in HCV cirrhotic patients after treatment with DAAs: A prospective multi-centric Italian study. PS-154.
WHO introduceert de ‘Toolkit for research and development of paediatric antiretroviral drugs and formulations’
sep 2019 | HIV